Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001421260 | SCV001623783 | likely benign | Carpenter syndrome | 2024-02-23 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004743475 | SCV005353297 | uncertain significance | RAB23-related disorder | 2024-08-20 | no assertion criteria provided | clinical testing | The RAB23 c.594T>G variant is not predicted to result in an amino acid change (p.=). This variant is predicted to alter splicing based on available splicing prediction software (SpliceAI, Jaganathan et al. 2019. PubMed ID: 30661751). However, the use of computer prediction softwares is not equivalent to functional evidence. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.024% of alleles in individuals of African descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |